|
GS204629: GO:1901564 organonitrogen compound metabolic process
|
|
GS185985: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
|
|
GS205510: GO:0001883 purine nucleoside binding
|
|
GS136137: lithogenic gene 18 (Lith18, Published QTL Chr 8)
|
|
GS189855: GO:0043168 anion binding
|
|
GS136045: insulin dependent diabetes susceptibility 22 (Idd22, Published QTL Chr 8)
|
|
GS202416: GO:0044711 single-organism biosynthetic process
|
|
GS204242: GO:0006767 water-soluble vitamin metabolic process
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS135547: CD4 T cell subset 3 (Cd4ts3, Published QTL Chr 8)
|
|
GS184984: GO:0032553 ribonucleotide binding
|
|
GS86911: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by morphine treatment (661). [DRG]
provisional
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS183645: GO:0017076 purine nucleotide binding
|
|
GS171194: HP:0001946 Ketosis
|
|
GS171902: HP:0010987 Abnormality of cellular immune system
|
|
GS135948: HDL QTL 16 (Hdlq16, Published QTL Chr 8)
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS197443: GO:0032549 ribonucleoside binding
|
|
GS86515: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). DBA/2J [DRG]
provisional
|
|
GS136657: skeletal muscle weight 16 (Skmw16, Published QTL Chr 8)
|
|
GS170783: HP:0010974 Abnormality of myeloid leukocytes
|
|
GS171243: HP:0003145 Decreased adenosylcobalamin
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS136061: immunoregulatory 3 (Im3, Published QTL Chr 8)
|
|
GS171893: HP:0011458 Abdominal symptom
|
|
GS196343: GO:0036094 small molecule binding
|
|
GS191106: GO:0044464 cell part
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS210137: GO:0016462 pyrophosphatase activity
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS172060: HP:0001508 Failure to thrive
|
|
GS176840: HP:0001911 Abnormality of granulocytes
|
|
GS178909: GO:0017111 nucleoside-triphosphatase activity
|
|
GS135449: bone length and organs 5 (Bod5, Published QTL Chr 8)
|
|
GS171453: HP:0003674 Onset
|
|
GS209108: GO:0000166 nucleotide binding
|
|
GS174292: HP:0011968 Feeding difficulties
|
|
GS86561: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). ALL [DRG]
provisional
|
|
GS175922: HP:0004341 Abnormality of the vitamin B12 metabolism
|
|
GS174763: HP:0010894 Abnormality of serine family amino acid metabolism
|
|
GS188652: GO:0001882 nucleoside binding
|
|
GS173155: HP:0005561 Abnormality of bone marrow cell morphology
|
|
GS173242: HP:0001337 Tremor
|
|
GS135883: femur geometry 7 (Fmgty7, Published QTL Chr 8)
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS176632: HP:0001903 Anemia
|
|
GS201799: GO:0032550 purine ribonucleoside binding
|
|
GS201800: GO:0032553 ribonucleotide binding
|
|
GS188651: GO:0001883 purine nucleoside binding
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS175383: HP:0003210 Decreased methylmalonyl-CoA mutase activity
|
|
GS175619: HP:0002098 Respiratory distress
|
|
GS199854: GO:0019001 guanyl nucleotide binding
|
|
GS136572: radiation induced acute myeloid leukemia 4 (Raml4, Published QTL Chr 8)
|
|
GS210113: GO:0033014 tetrapyrrole biosynthetic process
|
|
GS84205: chronic alcohol withdrawal severity (Published QTL, Chr 8)
|
|
GS173093: HP:0004372 Reduced consciousness/confusion
|
|
GS175390: HP:0011007 Age of onset
|
|
GS186744: GO:0043226 organelle
|
|
GS128597: Ethanol Induced Ataxia Chr#8
|
|
GS182835: GO:0005622 intracellular
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS173012: HP:0004364 Abnormality of nitrogen compound homeostasis
|
|
GS135540: cerebellum weight 2 (Cbm2, Published QTL Chr 8)
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS173015: HP:0003112 Abnormality of serum amino acid levels
|
|
GS189860: GO:0043167 ion binding
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS206742: GO:0043167 ion binding
|
|
GS202828: GO:0016817 hydrolase activity, acting on acid anhydrides
|
|
GS173534: HP:0001877 Abnormality of erythrocytes
|
|
GS135259: autoimmune extremity vasculitis in MRL mice 1 (Aevm1, Published QTL Chr 8)
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS135972: wound healing/regeneration 1 (Heal1, Published QTL Chr 8)
|
|
GS181473: GO:0005488 binding
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS175823: HP:0002093 Respiratory insufficiency
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS180644: GO:0032549 ribonucleoside binding
|
|
GS174137: HP:0002017 Nausea and vomiting
|
|
GS200675: GO:0009236 cobalamin biosynthetic process
|
|
GS171196: HP:0001944 Dehydration
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS207919: GO:0044283 small molecule biosynthetic process
|
|
GS172672: HP:0004337 Abnormality of amino acid metabolism
|
|
GS172415: HP:0002240 Hepatomegaly
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS198456: GO:0019438 aromatic compound biosynthetic process
|
|
GS177409: GO:0005739 mitochondrion
|
|
GS173535: HP:0001874 Abnormality of neutrophils
|
|
GS128577: Ethanol induced LORR Chr# 8
|
|
GS171305: HP:0012145 Abnormality of multiple cell lineages in the bone marrow
|
|
GS175529: HP:0000001 All
|
|
GS87158: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). DBA/2J [DRG]
provisional
|
|
GS194138: GO:0005739 mitochondrion
|
|
GS184447: GO:0044424 intracellular part
|
|
GS206737: GO:0043168 anion binding
|
|
GS183592: GO:0032561 guanyl ribonucleotide binding
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS136300: mean platelet volume locus 2 (Mpvq2, Published QTL Chr 8)
|
|
GS175825: HP:0002094 Dyspnea
|
|
GS173829: HP:0002912 Methylmalonic acidemia
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS135466: blood pressure QTL 23 (Bpq23, Published QTL Chr 8)
|
|
GS172066: HP:0001987 Hyperammonemia
|
|
GS204243: GO:0006766 vitamin metabolic process
|
|
GS135589: P. chabaudi malaria resistance QTL 2 (Char2, Published QTL Chr 8)
|
|
GS179580: GO:0036094 small molecule binding
|
|
GS194038: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS136672: skull morphology 11 (Skull11, Published QTL Chr 8)
|
|
GS172403: HP:0011873 Abnormal platelet count
|
|
GS136032: induction of brown adipocytes 3 (Iba3, Published QTL Chr 8)
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS171040: HP:0002157 Azotemia
|
|
GS174385: HP:0002088 Abnormality of the lung
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS206779: GO:0009110 vitamin biosynthetic process
|
|
GS182834: GO:0005623 cell
|
|
GS172745: HP:0010995 Abnormality of dicarboxylic acid metabolism
|
|
GS205511: GO:0001882 nucleoside binding
|
|
GS175918: HP:0002919 Ketonuria
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS199635: GO:0005622 intracellular
|
|
GS176038: HP:0002795 Functional respiratory abnormality
|
|
GS196943: GO:0008152 metabolic process
|
|
GS173537: HP:0001872 Abnormality of thrombocytes
|
|
GS87381: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
provisional
|
|
GS196941: GO:0008150 biological_process
|
|
GS199634: GO:0005623 cell
|
|
GS86497: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). C57BL/6J [DRG]
provisional
|
|
GS173647: HP:0012072 Aciduria
|
|
GS174133: HP:0002013 Vomiting
|
|
GS136390: autoimmune orchitis resistance 6 (Orch6, Published QTL Chr 8)
|
|
GS175827: HP:0010895 Abnormality of glycine metabolism
|
|
GS135252: adiposity 4 (Adip4, Published QTL Chr 8)
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS183053: GO:0019001 guanyl nucleotide binding
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS175805: HP:0003271 Visceromegaly
|
|
GS129101: bone mineral density 39 (Bmd39 Published QTL Chr 8)
|
|
GS204837: GO:0042364 water-soluble vitamin biosynthetic process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS135268: alopecia areata 3 (Alaa3, Published QTL Chr 8)
|
|
GS135780: exercise endurance QTL 2 (Eeq2, Published QTL Chr 8)
|
|
GS176186: HP:0000079 Abnormality of the urinary system
|
|
GS175172: HP:0004354 Abnormality of carboxylic acid metabolism
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS176168: HP:0001254 Lethargy
|
|
GS185881: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS185991: GO:0016817 hydrolase activity, acting on acid anhydrides
|
|
GS171789: HP:0001392 Abnormality of the liver
|
|
GS205180: GO:0005525 GTP binding
|
|
GS173028: HP:0004360 Abnormality of acid-base homeostasis
|
|
GS202716: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS203594: GO:0043226 organelle
|
|
GS195665: GO:0017111 nucleoside-triphosphatase activity
|
|
GS173130: HP:0001875 Neutropenia
|
|
GS136755: susceptibility to Salmonella typhimurium antigens 6 (Ssta6, Published QTL Chr 8)
|
|
GS200446: GO:0017076 purine nucleotide binding
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS184983: GO:0032550 purine ribonucleoside binding
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS192174: GO:0000166 nucleotide binding
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS172158: HP:0100508 Abnormality of vitamin metabolism
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS194087: GO:0003674 molecular_function
|
|
GS173026: HP:0000816 Abnormality of Krebs cycle metabolism
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS173533: HP:0001876 Pancytopenia
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS176610: HP:0003593 Infantile onset
|
|
GS136533: preaxial shift (Prxsh, Published QTL Chr 8)
|
|
GS175119: HP:0001881 Abnormality of leukocytes
|
|
GS171201: HP:0001941 Acidosis
|
|
GS176175: HP:0001259 Coma
|
|
GS136313: non-HDL QTL 1 (Nhdlq1, Published QTL Chr 8)
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS203886: GO:1901265 nucleoside phosphate binding
|
|
GS135989: Hfe modifier 2 (Hfem2, Published QTL Chr 8)
|
|
GS204631: GO:1901566 organonitrogen compound biosynthetic process
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS172687: HP:0012120 Methylmalonic aciduria
|
|
GS84206: METH responses for body temperature (Published QTL, Chr 8)
|
|
GS173577: HP:0011991 Abnormal neutrophil cell number
|
|
GS175537: HP:0011277 Abnormality of the urinary system physiology
|
|
GS136068: immune response to AAV2 QTL 2 (Imraq2, Published QTL Chr 8)
|
|
GS184978: GO:0032555 purine ribonucleotide binding
|
|
GS87045: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). SWR/J [DRG]
provisional
|
|
GS135913: glomerulsclerosis index 1 (Gsi1, Published QTL Chr 8)
|
|
GS171198: HP:0001942 Metabolic acidosis
|
|
GS135613: circulating hormone level QTL 5 (Chlq5, Published QTL Chr 8)
|
|
GS172438: HP:0002154 Hyperglycinemia
|
|
GS86517: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). 129P3/J [DRG]
provisional
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS188323: GO:0005525 GTP binding
|
|
GS193193: GO:0016462 pyrophosphatase activity
|
|
GS175380: HP:0003215 Dicarboxylic aciduria
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS201794: GO:0032555 purine ribonucleotide binding
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS210114: GO:0033013 tetrapyrrole metabolic process
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS187023: GO:1901265 nucleoside phosphate binding
|
|
GS198263: GO:0005488 binding
|
|
GS136920: vertebral morphology and mechanical traits 8 (Vmmt8, Published QTL Chr 8)
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS176040: HP:0011032 Abnormality of fluid regulation
|
|
GS135397: body growth early QTL 7 (Bgeq7, Published QTL Chr 8)
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS172365: HP:0003110 Abnormality of urine homeostasis
|
|
GS136512: prion incubation time 3 (Pitm3, Published QTL Chr 8)
|
|
GS135717: despair 1 (Desp1, Published QTL Chr 8)
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS172362: HP:0004325 Decreased body weight
|
|
GS173538: HP:0001873 Thrombocytopenia
|
|
GS135844: femoral cross-sectional area 2 (Fcsa2, Published QTL Chr 8)
|
|
GS171637: HP:0008872 Feeding difficulties in infancy
|
|
GS206953: GO:0018130 heterocycle biosynthetic process
|
|
GS136369: obesity QTL 16 (Obq16, Published QTL Chr 8)
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS180164: GO:0008150 biological_process
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS175925: HP:0004340 Abnormality of vitamin B metabolism
|
|
GS136355: novelty/stress induced locomotor activation 6 (Nsila6, Published QTL Chr 8)
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS202822: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS200678: GO:0009235 cobalamin metabolic process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS200393: GO:0032561 guanyl ribonucleotide binding
|
|
GS186743: GO:0043227 membrane-bounded organelle
|